KOSDAQ

VALOFE Launches Summer Cashback Promotion Offering Up to 20%

Bonus V-Coins to Be Awarded Based on VFUN Transaction Amounts from the 17th to the 19th Major Summer Updates for Popular Games Also Rolled Out

Hyera Lee
2026-07-16 09:40:02
[Edaily Reporter Hyera Lee ] VALOFE(331520)announced on the 16th that it will run a cashback promotion offering up to 20% to VFUN payment users for three days starting on the 17th.
Photo related to the event. (Photo = VALOFE)

This promotion awards 10–20% bonus V-Coins based on the payment amount, and these bonus V-Coins can be used in the same way as regular V-Coins.
The company’s games will also feature summer-themed updates and events.
"Last Origin" will introduce a new character, "Charybdis." To celebrate the launch, the game will offer discounts on swimsuit skins and unveil new skins.
'Altubeat' is introducing a revamped privacy UI designed for greater user convenience, along with a host of new content such as 'Super Practice Mode.' It will also add new costumes and AI-generated music tracks.
"Icarus" will implement an update that adjusts class skill balances and raises the maximum enhancement level for the Immortal God Enhancement Stone from Level 22 to Level 23.
VALOFE plans to continue rolling out a variety of events in the future.

Economy

Corporation

IT·Science

Economy

Samsung INICS Corporation Awaits ‘Record-Breaking Earnings’… Will It Unveil More Shareholder Returns?

Expectations are growing for additional shareholder returns from SamsungElectronics and SK hynix ahead of their upcoming record-breaking earnings announcements. This comes as the two companies’ combin…
2026-10-26 16:04:59

Corporation

Engineering Job Postings Rise 14-Fold… Wanted Lab Inc. Helps Match Talent

Wanted Lab Inc.(376980)is hosting an in-person job fair to directly connect developers with companies in response to growing demand for "Chonbang Engineers" (FDE). Photo courtesy of WantedLab Inc.…
2026-10-26 15:07:27

IT·Science

SillaJen, Inc.’s BAL0891 Demonstrates Anticancer Efficacy at the European Society for Medical Oncology Conference… Response Rate of 21.4% in Combination Therapy Group

SillaJen, Inc.(215600)has confirmed initial antitumor effects in a Phase 1 clinical trial of its new anticancer drug candidate, “BAL0891,” currently under development. In an interim analysis of patien…
2026-10-26 15:11:02